Literature DB >> 30580675

A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors.

Jennifer Barsky Reese1,2, Katherine Clegg Smith3,4, Elizabeth Handorf5, Kristen Sorice1, Sharon L Bober6, Elissa T Bantug4, Sharon Schwartz7, Laura S Porter8.   

Abstract

The purpose was to test the feasibility, acceptability, and preliminary efficacy of a 4-session couple-based Intimacy Enhancement (IE) intervention addressing breast cancer survivors' sexual concerns delivered via telephone. Twenty-nine post-treatment breast cancer survivors reporting sexual concerns and their intimate partners were randomized (2:1) to the IE intervention or to an educational control condition, both of which were delivered by trained psychosocial providers. Feasibility and acceptability were measured through recruitment, retention, session completion, and post-intervention program evaluations. Couples completed validated sexual, relationship, and psychosocial outcome measures at pre- and post-intervention. Between-group effect sizes and 95% confidence intervals were calculated using the Hedges g. Data supported intervention feasibility and acceptability. For survivors, the IE intervention had medium to large positive effects on all sexual outcomes and most psychosocial outcomes. Effects were less visible for relationship outcomes and were similar but somewhat smaller for partners. The IE intervention demonstrated feasibility, acceptability, and promise in addressing breast cancer survivors' sexual concerns and enhancing their and their partners' intimate relationships and psychosocial well-being. Implications for Psychosocial Oncology Practice The IE intervention demonstrated feasibility and acceptability, suggesting it could be well-received by breast cancer survivors with sexual concerns and their partners. Effects of the IE intervention on breast cancer survivors' sexual concerns and on their and their partners' intimate relationships and psychosocial well-being could not be attributed to therapist time and attention. Interventions that psychosocial providers can use to address breast cancer survivors' sexual concerns are important to the growing number of breast cancer survivors living for many years after their diagnosis.

Entities:  

Keywords:  breast cancer; couple therapy; interventions; sexual dysfunction; sexuality

Mesh:

Year:  2018        PMID: 30580675      PMCID: PMC6476670          DOI: 10.1080/07347332.2018.1510869

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  11 in total

1.  Why do breast cancer survivors decline a couple-based intimacy enhancement intervention trial?

Authors:  Jennifer Barsky Reese; Kristen A Sorice; Natalie M Oppenheimer; Katherine Clegg Smith; Sharon L Bober; Elissa T Bantug; Sharon C Schwartz; Laura S Porter
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

2.  Patients' perceived barriers to discussing sexual health with breast cancer healthcare providers.

Authors:  Lauren A Zimmaro; Stephen J Lepore; Mary Catherine Beach; Jennifer B Reese
Journal:  Psychooncology       Date:  2020-04-16       Impact factor: 3.894

3.  Telephone interventions for symptom management in adults with cancer.

Authors:  Emma Ream; Amanda Euesden Hughes; Anna Cox; Katy Skarparis; Alison Richardson; Vibe H Pedersen; Theresa Wiseman; Angus Forbes; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2020-06-02

4.  Evaluating a couple-based intervention addressing sexual concerns for breast cancer survivors: study protocol for a randomized controlled trial.

Authors:  Jennifer Barsky Reese; Lauren A Zimmaro; Stephen J Lepore; Kristen A Sorice; Elizabeth Handorf; Mary B Daly; Leslie R Schover; Deborah Kashy; Kelly Westbrook; Laura S Porter
Journal:  Trials       Date:  2020-02-12       Impact factor: 2.279

5.  Adapting a Theory-Informed Intervention to Help Young Adult Couples Cope With Reproductive and Sexual Concerns After Cancer.

Authors:  Jessica R Gorman; Karen S Lyons; Jennifer Barsky Reese; Chiara Acquati; Ellie Smith; Julia H Drizin; John M Salsman; Lisa M Flexner; Brandon Hayes-Lattin; S Marie Harvey
Journal:  Front Psychol       Date:  2022-02-04

6.  Investigating the impact of the COVID-19 pandemic on breast cancer clinicians' communication about sexual health.

Authors:  Jennifer Barsky Reese; Areej El-Jawahri; Kristen Sorice; Christina Cruz; Sharon L Bober; Mary B Daly; Lauren A Zimmaro; Mary Catherine Beach; Elaine Wittenberg; Antonio C Wolff; Elizabeth Handorf; Stephen J Lepore
Journal:  Support Care Cancer       Date:  2022-03-29       Impact factor: 3.359

7.  Coping With Changes to Sex and Intimacy After a Diagnosis of Metastatic Breast Cancer: Results From a Qualitative Investigation With Patients and Partners.

Authors:  Jennifer Barsky Reese; Lauren A Zimmaro; Sarah McIlhenny; Kristen Sorice; Laura S Porter; Alexandra K Zaleta; Mary B Daly; Beth Cribb; Jessica R Gorman
Journal:  Front Psychol       Date:  2022-04-06

8.  Opening the Conversation: study protocol for a Phase III trial to evaluate a couple-based intervention to reduce reproductive and sexual distress among young adult breast and gynecologic cancer survivor couples.

Authors:  Jessica R Gorman; Karen S Lyons; S Marie Harvey; Chiara Acquati; John M Salsman; Deborah A Kashy; Julia H Drizin; Ellie Smith; Lisa M Flexner; Brandon Hayes-Lattin; Jennifer B Reese
Journal:  Trials       Date:  2022-09-02       Impact factor: 2.728

9.  The Challenges of Enrollment and Retention: A Systematic Review of Psychosocial Behavioral Interventions for Patients With Cancer and Their Family Caregivers.

Authors:  Lixin Song; Yousef Qan'ir; Ting Guan; Peiran Guo; Shenmeng Xu; Ahrang Jung; Eno Idiagbonya; Fengyu Song; Erin Elizabeth Kent
Journal:  J Pain Symptom Manage       Date:  2021-04-30       Impact factor: 5.576

Review 10.  Interventions to Improve Sexual Health in Women Living with and Surviving Cancer: Review and Recommendations.

Authors:  Jenna Sopfe; Jessica Pettigrew; Anosheh Afghahi; Leslie C Appiah; Helen L Coons
Journal:  Cancers (Basel)       Date:  2021-06-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.